Overactive Bladder Management: Challenges and Opportunities

FEBRUARY 22, 2012
Mary Barna Bridgeman, PharmD, BCPS, CGP and Christina Taft, PharmD

Pharmacy Times Office of Continuing Professional Education


Overactive Bladder Management: Challenges and Opportunities

Mary Barna Bridgeman, PharmD, BCPS, CGP

Clinical Assistant Professor

Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey; Piscataway, NJ

Internal Medicine Clinical Pharmacist

Capital Health Regional Medical Center; Trenton, NJ

Christina Taft, PharmD

Post-Graduate Year-1 Pharmacy Resident

Capital Health Regional Medical Center; Trenton, NJ


Mary Barna Bridgeman, PharmD, BCPS, CGP, and Christina Taft, PharmD, have no relevant affiliations or financial relationships to disclose related to this acitivity.

Judy V. Lum, MPA; Elena Beyzarov, PharmD; Ann C. Lichti, CCMEP; and Donna Fausak of the Pharmacy Times Office of Continuing Professional Education have no relevant affiliations or financial relationships to disclose related to this activity.

Bea Riemschneider, Jennifer Barrio, and David Allikas of Pharmacy Times Editorial have no relevant affiliations or financial relationships to disclose related to this activity.


Educational Objectives

Upon completion of this educational activity, participants should be able to:

  1. Recognize the prevalence and burden associated with overactive bladder (OAB) syndrome.
  2. Understand the impact of OAB on patients and their quality of life.
  3. Evaluate current and emerging agents for the management of OAB and their role in the treatment paradigm.
  4. Counsel patients effectively about their OAB medication, side effects, and the importance of adherence.

Target audience: Pharmacists

Type of activity: Knowledge

Release date: February 10, 2012

Expiration date: February 10, 2014

Estimated time to complete activity: 1.5 hours

Fee: This lesson is free online

Click here to view this activity.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.